Related Experiment Video
Updated: Dec 13, 2025

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Mid-Term Outcomes of Patients with Central Venous Occlusive Disease Undergoing Surveillance Venography and
Hui Lin Wong1, Shaun Xavier Jm Chan, Satheesh Ramamuthy
1Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore.
Insights
Regular surveillance venography with percutaneous transluminal angioplasty (PTA) can achieve high patency rates in haemodialysis patients with central venous occlusive disease (CVOD). However, central venous occlusions (CVOs) are more challenging to treat than central venous stenosis (CVS).
Area of Science:
- Vascular Surgery
- Nephrology
- Interventional Radiology
Background:
- Central venous occlusive disease (CVOD) is a significant complication in haemodialysis patients.
- Management strategies for CVOD, including surveillance venography and percutaneous transluminal angioplasty (PTA), require evaluation.
Purpose of the Study:
- To assess the mid-term outcomes of surveillance venography with or without PTA in haemodialysis patients with CVOD.
- To compare outcomes between central venous occlusion (CVO) and central venous stenosis (CVS).
Main Methods:
- Retrospective analysis of 77 patients with central venous stenosis (CVS) and 35 patients with central venous occlusion (CVO) between 2008-2011.
- Patients underwent PTA for significant stenosis (>50%) or occlusion (100%) and were followed with surveillance venography every 3-6 months.
- Technical success, primary patency, and primary assisted patency were analyzed.
Main Results:
- Technical success rates for initial PTA were 77% for CVO and 73% for CVS.
- Primary assisted patency at 1 year was 88% for CVO and 99% for CVS (P=0.009).
- Overall primary assisted patency showed a significant difference between CVO and CVS groups (P=0.048).
Conclusions:
- Central venous occlusions (CVOs) present greater treatment challenges than central venous stenosis (CVS).
- Surveillance venography, coupled with repeat interventions, can yield high primary assisted patency rates.
- Further cost-effectiveness studies are warranted to determine the full benefit of surveillance programs.
Introduction:
To evaluate the mid-term outcomes of regular surveillance venography with or without percutaneous transluminal angioplasty (PTA) in haemodialysis patients presenting with central venous occlusive disease.
Materials And Methods:
A single-centre retrospective analysis of haemodialysis patients who presented with central vein occlusion (CVO) and central vein stenosis (CVS) between January 2008 and December 2011 was performed. CVO and significant CVS were defined as 100% and >50% luminal narrowing, respectively. Upon successful angioplasty on first presentation, patients were followed up with regular surveillance venography within 3-6 months of the intervention and were re-treated when a significant stenosis or occlusion was demonstrated. Data on patient's demographics, comorbidities, presenting symptoms, type of upper limb dialysis access, lesion characteristics and complications were collected. Technical success, primary patency and primary assisted patency were analysed.
Results:
Thirty-five patients with CVO and 77 patients with CVS were enrolled. The technical success of initial PTA was 77% and 73% for the CVO and CVS groups, respectively. The primary patency at 3 months was 65% and 55% for the CVO group and CVS group, respectively (P = 0.32). The primary assisted patency at 1 year was 88% and 99% for the CVO group and CVS group, respectively (P = 0.009). At 2 years, the primary assisted patency were 77% and 90%, respectively (P = 0.07). There was significant difference in the overall primary assisted patency (P = 0.048) between the CVO and CVS groups.
Conclusion:
CVOs are more difficult to treat than CVS. High primary assisted patency rates can be achieved with surveillance venography, albeit at the expense of increased number of interventions. Further cost effectiveness studies need to be performed to study the true benefit of our surveillance programme.
More Related Videos
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Endocarditis III: Medical Management

